Godin Andre 4

4 · IntelGenx Technologies Corp. · Filed Jan 31, 2023

Form 4

Period: 2023-01-29

EVP + CFO

Transactions

Award
Restricted Share Units (p.v.0.00001)
2023-01-29+100,000→ 123,077 total
Exercise: $0.00Exp: 2026-01-28→ Common Stock (100,000 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+33,750→ 1,093,720 total
Exercise: $0.24From: 2024-01-29Exp: 2033-01-28→ Common Stock (33,750 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+33,750→ 1,127,470 total
Exercise: $0.24From: 2025-01-29Exp: 2033-01-28→ Common Stock (33,750 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+33,750→ 1,161,220 total
Exercise: $0.24From: 2026-01-29Exp: 2033-01-28→ Common Stock (33,750 underlying)
Award
Options (right to buy) p.v.0.00001
2023-01-29+33,750→ 1,194,970 total
Exercise: $0.24From: 2027-01-29Exp: 2033-01-28→ Common Stock (33,750 underlying)

Footnotes (2)

[F1]The award vests as follows: 25% on each of January 29, 2024; 2025; 2026 and 2027, each vesting subject to acceleration upon Issuer???s common stock achieving a specified price per share.
[F2]Each performance right represents a contingent right to receive one share of Issuer???s common stock. The performance rights vest upon Issuer???s common stock achieving a specified price per share.

Documents

1 file